Danish ethics council okays therapeutic cloning:
This article was originally published in Clinica
The Danish Council for Ethics has agreed to allow the use of stem cells in therapeutic cloning. A majority decision agreed to restrict research into the possibility of therapeutic cloning, so that only fertilised eggs left over during infertility treatment are used. The council has, however, categorically rejected any moves towards reproductive cloning, labelling it as highly unethical. Jesper Poulsen, head of the Danish association of doctors (Laegeforeningen), agrees with this measure, and welcomed the decision on therapeutic cloning.
You may also be interested in...
The amyloid-targeting drug is years behind Biogen/Eisai’s aducanumab, but its subcutaneous administration and the GRADUATE studies’ design could give Roche’s gantenerumab an advantage.
Correvio's atrial fibrillation drug Brinavess will return to a US FDA advisory committee more than a decade after the agency first declined to approve the drug; FDA still has a series of cardiovascular safety concerns related to the drug and is not convinced by data from the European experience.
FerGene bladder cancer therapy achieved a complete response in more than half of patients in its pivotal trial. The joint venture now looks to commercialization and potential expansion of indications.